Sunitinib in Patients with Pre-Treated Pancreatic Neuroendocrine Tumors: A Real-World Study

被引:0
|
作者
Rinzivillo, M. [1 ]
Gritti, S. [2 ]
Pusceddu, S. [3 ]
Spallanzani, A. [4 ]
Ibrahim, T. [5 ]
Brighi, N. [6 ]
Marconcini, R. [7 ,8 ]
Partelli, S. [9 ]
Badalamenti, G. [10 ]
Catena, L. [11 ]
Schinzari, G. [12 ]
Panzuto, F. [1 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, ENETS Ctr Excellence, Digest & Liver Diseaes, Rome, Italy
[2] ENETS Ctr Excellence IEO, Div Gastrointestinal Med Oncol & Neuroendocrine, Milan, Italy
[3] Fdn IRCCS, ENETS Ctr Excellence, Dept Med Oncol, Ist Tumori Milano, Milan, Italy
[4] Univ Hosp Modena, Dept Haematol & Oncol, Div Oncol, Modena, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Osteoncol & Rare Tumors Ctr, Meldola, Italy
[6] S Orsola Malpighi Univ Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[7] Univ Pisana, Azienda Osped, Dept Oncol, Pisa, Italy
[8] Univ Pisa, Ist Toscano Tumori, Santa Chiara Hosp, Pisa, Italy
[9] Vita & Salute Univ, Div Pancreat Surg, Pancreas Translat & Clin Res Ctr, San Raffaele Sci Inst, Milan, Italy
[10] Univ Palermo, Dept Surg & Oncol Sci, Palermo, Italy
[11] Struttura Oncol Policlin Monza, Monza, Italy
[12] Univ Cattolica Sacro Cuore, Med Oncol, Rome, Italy
关键词
sunitinib; neuroendocrine tumors; pancreas; progressive disease; target therapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
I09
引用
下载
收藏
页码:217 / 217
页数:1
相关论文
共 50 条
  • [1] Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study
    Rinzivillo, Maria
    Fazio, Nicola
    Pusceddu, Sara
    Spallanzani, Andrea
    Ibrahim, Toni
    Campana, Davide
    Marconicini, Riccardo
    Partelli, Stefano
    Badalamenti, Giuseppe
    Brizzi, Maria Pia
    Catena, Laura
    Schinzari, Giovanni
    Carnaghi, Carlo
    Berardi, Rossana
    Faggiano, Antongiulio
    Antonuzzo, Lorenzo
    Spada, Francesca
    Gritti, Sara
    Femia, Daniela
    Gelsomino, Fabio
    Bongiovanni, Alberto
    Ricci, Sergio
    Brighi, Nicole
    Falconi, Massimo
    Delle Fave, Gianfranco
    Panzuto, Francesco
    PANCREATOLOGY, 2018, 18 (02) : 198 - 203
  • [2] Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
    Kazuo Sato
    Yasuharu Toyoshima
    Shiho Moriyama
    Yutaka Endo
    Tetsuhide Ito
    Emiko Ohki
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 201 - 207
  • [3] Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
    Sato, Kazuo
    Toyoshima, Yasuharu
    Moriyama, Shiho
    Endo, Yutaka
    Ito, Tetsuhide
    Ohki, Emiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (01) : 201 - 207
  • [4] Real-World Data of Nivolumab and Pembrolizumab in Chemotherapy Pre-Treated Mesothelioma Patients
    Dumoulin, D.
    Cantini, L.
    Belderbos, R.
    Mercieca, D.
    Cornelissen, R.
    Aerts, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S267 - S267
  • [5] Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients
    Mauro, Carine
    de Jesus, Victor Hugo Fonseca
    Barros, Milton
    Costa, Frederico Perego
    Weschenfelder, Rui F.
    D'Agustini, Nathalia
    Angel, Martin
    Luca, Romina
    Nunez, Jose Eduardo
    O'Connor, Juan Manuel
    Riechelmann, Rachel P.
    NEUROENDOCRINOLOGY, 2021, 111 (07) : 631 - 638
  • [6] A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The 'PROTOR' Study
    Kaltsas, Gregory
    Andreadis, Charalambos
    Kosmidis, Paraskevas
    Mavroudis, Dimitrios
    Pazaitou-Panayiotou, Kalliopi
    Vaslamatzis, Michail
    Athanasiadis, Ilias
    ANTICANCER RESEARCH, 2022, 42 (04) : 1941 - 1948
  • [7] A Real-World Study of Bendamustine Therapy in a Very Heavily Pre-Treated Population of Multiple Myeloma Patients
    Bird, Sarah
    Panopoulou, Akaterina
    Kaiser, Martin
    Boyd, Kevin
    Pawlyn, Charlotte
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S424 - S424
  • [8] A 'real-world' study of panobinostat, bortezomib and dexamethasone in a very heavily pre-treated population of myeloma patients
    Bird, Sarah
    Sriskandarajah, Priya
    Kaiser, Martin
    Pawlyn, Charlotte
    Boyd, Kevin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E244 - E245
  • [9] Real-world outcomes with nivolumab for pre-treated malignant mesothelioma in the UK
    Morton, Cienne
    Gennatas, Spyridon
    Holden, Sophia
    Karapanagiotou, Eleni
    Spicer, James
    Georgiou, Alexandros
    LUNG CANCER, 2022, 165 : S27 - S27
  • [10] Sunitinib in pancreatic neuroendocrine tumors
    Raymond, Eric
    Hammel, Pascal
    Dreyer, Chantal
    Maatescu, Christian
    Hentic, Olivia
    Ruszniewski, Philippe
    Faivre, Sandrine
    TARGETED ONCOLOGY, 2012, 7 (02) : 117 - 125